The platform uses a DEXA scan and T-scores to create implants that match a patient’s bone density. These implants improve outcomes around bone fusion treatments.
Aurora Spine is marketing the platform as part of its “advanced portfolio representing the future of spinal and orthopedic implants,” the company said in a release.
Aurora Spine CEO Trent Northcutt said, “The DEXA opportunity represents our continued commitment to delivering best-in-class implants that enable our surgeon partners to overcome common osteoporosis challenges faced in traditional procedures.”
The company expects to begin commercialization efforts in the coming months.
More articles on surgery centers:
12-OR ASC part of $295M Florida orthopedic hospital expansion
3 ASCs launching total joint programs
4 ASCs installing total joint robots
